Publication | Closed Access
Antiviral activity of Norakin (triperiden) and related anticholinergic antiparkinsonism drugs.
13
Citations
0
References
1984
Year
Antiparkinsonism ActivitiesMedicinal ChemistryAnticholinergic Antiparkinsonism DrugsAntiviral AgentsSynthetic VirologyMedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyNeuropharmacologyPharmacotherapyAntiviral DrugMeasles VirusAntiparkinsonism DrugsPharmacologyAntiviral CompoundDrug Discovery
In view of the coincidence of antiviral and antiparkinsonism activities of amantadine four antiparkinsonism drugs, NorakinR (triperiden), ParkopanR (trihexyphenidyl), AntiparkinR (diethylbenzhydramine) and AkinetonR (biperiden) were tested for antiviral activity in various virus-cell systems. Norakin inhibited the replication of influenza A viruses in chick embryo fibroblast, MDCK and Ehrlich ascites tumour cells. It also inhibited the replication of measles virus in Vero cells, 50% inhibitory concentrations being 2-6 micrograms/ml. The drugs were also active against influenza B virus. Several representatives of other virus families, e.g. vaccinia, vesicular stomatitis, polio type 1 and herpes simplex type 1 viruses were insensitive to the compounds.